Karyopharm Therapeutics (NASDAQ:KPTI) reported top-line results from its phase III SENTRY trial evaluating selinexor in ...

Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used ...

VANCOUVER, Washington, Feb. 20, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized ...

Antimicrobial resistance (AMR) poses a major global health challenge by compromising the effectiveness of current therapies for infectious diseases. While ...

MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (GNTA), a pioneer in immuno-oncology, today announced that a total of 38 patients were enrolled in newly diagnosed glioblastoma ...

Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns the liver into a short‑lived factory for powerful T‑cell survival signals.

Marseille, France, December 7, 2025, 5:30 pm ET/ 11:30 pm CET – ImCheck Therapeutics today announced updated results from its Phase I/II EVICTION study evaluating ICT01, a first-in-class γ9δ2 T-cell ...